BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9211750)

  • 1. Association of human NK cell surface receptors NKR-P1 and CD94 with Src-family protein kinases.
    Cerný J; Fiserová A; Horváth O; Bezouska K; Pospísil M; Horejsí V
    Immunogenetics; 1997; 46(3):231-6. PubMed ID: 9211750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
    Ding Y; Sumitran S; Holgersson J
    Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytoplasmic domain of rat NKR-P1 receptor interacts with the N-terminal domain of p56(lck) via cysteine residues.
    Campbell KS; Giorda R
    Eur J Immunol; 1997 Jan; 27(1):72-7. PubMed ID: 9022000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells.
    Palmieri G; Tullio V; Zingoni A; Piccoli M; Frati L; Lopez-Botet M; Santoni A
    J Immunol; 1999 Jun; 162(12):7181-8. PubMed ID: 10358164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional requirements for signaling through the stimulatory and inhibitory mouse NKR-P1 (CD161) NK cell receptors.
    Ljutic B; Carlyle JR; Filipp D; Nakagawa R; Julius M; Zúñiga-Pflücker JC
    J Immunol; 2005 Apr; 174(8):4789-96. PubMed ID: 15814704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.
    Cantoni C; Biassoni R; Pende D; Sivori S; Accame L; Pareti L; Semenzato G; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 1998 Jan; 28(1):327-38. PubMed ID: 9485212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
    J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.
    Van Beneden K; Stevenaert F; De Creus A; Debacker V; De Boever J; Plum J; Leclercq G
    J Immunol; 2001 Apr; 166(7):4302-11. PubMed ID: 11254682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function.
    Carlyle JR; Martin A; Mehra A; Attisano L; Tsui FW; Zúñiga-Pflücker JC
    J Immunol; 1999 May; 162(10):5917-23. PubMed ID: 10229828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors.
    Boyington JC; Riaz AN; Patamawenu A; Coligan JE; Brooks AG; Sun PD
    Immunity; 1999 Jan; 10(1):75-82. PubMed ID: 10023772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells.
    Arase N; Arase H; Park SY; Ohno H; Ra C; Saito T
    J Exp Med; 1997 Dec; 186(12):1957-63. PubMed ID: 9396764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells.
    Ryan JC; Naper C; Hayashi S; Daws MR
    Immunol Rev; 2001 Jun; 181():126-37. PubMed ID: 11513134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD94/NKG2 C-type lectin receptor complex: involvement in NK cell-mediated recognition of HLA class I molecules.
    López-Botet M; Carretero M; Pérez-Villar J; Bellón T; Llano M; Navarro F
    Immunol Res; 1997; 16(2):175-85. PubMed ID: 9212363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage of the NKG2 and CD94 receptor genes to D12S77 in the human natural killer gene complex.
    Sobanov Y; Glienke J; Brostjan C; Lehrach H; Francis F; Hofer E
    Immunogenetics; 1999 Feb; 49(2):99-105. PubMed ID: 9887346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
    Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
    J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals.
    André P; Brunet C; Guia S; Gallais H; Sampol J; Vivier E; Dignat-George F
    Eur J Immunol; 1999 Apr; 29(4):1076-85. PubMed ID: 10229073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
    Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.
    Carretero M; Cantoni C; Bellón T; Bottino C; Biassoni R; Rodríguez A; Pérez-Villar JJ; Moretta L; Moretta A; López-Botet M
    Eur J Immunol; 1997 Feb; 27(2):563-7. PubMed ID: 9045931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.